发明名称 METHOD FOR PREDICTING THE RESPONSE TO HER2-DIRECTED THERAPY
摘要 This invention provides methods for determining or predicting response to HER2-directed therapy in an individual.
申请公布号 US2016091493(A1) 申请公布日期 2016.03.31
申请号 US201514965402 申请日期 2015.12.10
申请人 Cell Signaling Technology, Inc. ;Ventana Medical Systems, Inc. 发明人 Bacus Sarah S.;Smith Bradley L.
分类号 G01N33/574 主分类号 G01N33/574
代理机构 代理人
主权项 1. A method for identifying a mammalian tumor that responds to a HER2-directed therapy, wherein the mammalian tumor overexpresses HER2, the method comprising the step of assaying a sample obtained from the mammalian tumor to detect a pattern of expression, phosphorylation or both expression and phosphorylation of one or a plurality of polypeptides consisting of: (a) IGFR polypeptide; (b) EGFR polypeptide; (c) NDF polypeptide; (d) phosphorylated S6 ribosomal polypeptide; (e) phosphorylated AKT polypeptide; and (f) phosphorylated ERK polypeptide; wherein the detected pattern of expression, phosphorylation or both expression and phosphorylation identifies mammalian tumors that respond to a HER2-directed therapy.
地址 Beverly MA US